These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28689023)

  • 21. A novel mixed integer programming for multi-biomarker panel identification by distinguishing malignant from benign colorectal tumors.
    Zou M; Zhang PJ; Wen XY; Chen L; Tian YP; Wang Y
    Methods; 2015 Jul; 83():3-17. PubMed ID: 25980368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
    Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levels of serum-soluble receptor for interleukin-2 in patients with colorectal cancer.
    Saito H; Tsujitani S; Katano K; Ikeguchi M; Maeta M; Kaibara N
    Surg Today; 1998; 28(10):1115-7. PubMed ID: 9786595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subsite heterogeneity in the profiles of circulating cytokines in colorectal cancer.
    Krzystek-Korpacka M; Zawadzki M; Kapturkiewicz B; Lewandowska P; Bednarz-Misa I; Gorska S; Witkiewicz W; Gamian A
    Cytokine; 2018 Oct; 110():435-441. PubMed ID: 29801973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating midkine in malignant and non-malignant colorectal diseases.
    Krzystek-Korpacka M; Diakowska D; Neubauer K; Gamian A
    Cytokine; 2013 Oct; 64(1):158-64. PubMed ID: 23899719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CA11-19: a tumor marker for the detection of colorectal cancer.
    Overholt BF; Wheeler DJ; Jordan T; Fritsche HA
    Gastrointest Endosc; 2016 Mar; 83(3):545-51. PubMed ID: 26318832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
    Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
    J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
    Linkov F; Lisovich A; Yurkovetsky Z; Marrangoni A; Velikokhatnaya L; Nolen B; Winans M; Bigbee W; Siegfried J; Lokshin A; Ferris RL
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):102-7. PubMed ID: 17220337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic and cytokine plasma biomarkers for predicting progression from colorectal adenoma to carcinoma in human patients.
    Choi JW; Liu H; Shin DH; Yu GI; Hwang JS; Kim ES; Yun JW
    Proteomics; 2013 Aug; 13(15):2361-74. PubMed ID: 23606366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.
    Chen H; Werner S; Butt J; Zörnig I; Knebel P; Michel A; Eichmüller SB; Jäger D; Waterboer T; Pawlita M; Brenner H
    Oncotarget; 2016 Mar; 7(13):16420-32. PubMed ID: 26909861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage mannose receptor 1 and S100A9 were identified as serum diagnostic biomarkers for colorectal cancer through a label-free quantitative proteomic analysis.
    Fan NJ; Chen HM; Song W; Zhang ZY; Zhang MD; Feng LY; Gao CF
    Cancer Biomark; 2016; 16(2):235-43. PubMed ID: 26682511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
    Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
    BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Perioperative immunologic changes in colorectal cancer patients].
    Neagu S; Lerescu L; Costea R; Tucureanu C; Caraş I; Gangură G; Pitica R; Sălăgeanu A
    Chirurgia (Bucur); 2012; 107(1):59-65. PubMed ID: 22480118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients.
    Cao Y; Luetkens T; Kobold S; Hildebrandt Y; Gordic M; Lajmi N; Meyer S; Bartels K; Zander AR; Bokemeyer C; Kröger N; Atanackovic D
    Exp Hematol; 2010 Oct; 38(10):860-7. PubMed ID: 20619313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating inflammatory factors associated with worse long-term prognosis in colorectal cancer.
    Olsen RS; Nijm J; Andersson RE; Dimberg J; Wågsäter D
    World J Gastroenterol; 2017 Sep; 23(34):6212-6219. PubMed ID: 28974887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of potential colorectal cancer serum biomarkers through quantitative proteomics on the colonic tissue interstitial fluids from the AOM-DSS mouse model.
    Wang Y; Shan Q; Hou G; Zhang J; Bai J; Lv X; Xie Y; Zhu H; Su S; Li Y; Zi J; Lin L; Han W; Zhao X; Wang H; Xu N; Wu L; Lou X; Liu S
    J Proteomics; 2016 Jan; 132():31-40. PubMed ID: 26581642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of serum interleukin-17 levels in colorectal cancer patients.
    Karabulut S; Usul Afsar C; Karabulut M; Kilic L; Alis H; Kones O; Bilgin E; Faruk Aykan N
    J BUON; 2016; 21(5):1137-1145. PubMed ID: 27837615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
    Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic value of carcinoembryonic antigen combined with cytokines in serum of patients with colorectal cancer.
    Ma Y; Zhang Y; Bi Y; He L; Li D; Wang D; Wang M; Wang X
    Medicine (Baltimore); 2022 Sep; 101(37):e30787. PubMed ID: 36123861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiplexed VeraCode bead-based serological immunoassay for colorectal cancer.
    Ostendorff HP; Awad A; Braunschweiger KI; Liu Z; Wan Z; Rothschild KJ; Lim MJ
    J Immunol Methods; 2013 Dec; 400-401():58-69. PubMed ID: 24161315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.